Inside Innovation

In KPMG’s 2023 Healthcare and Life Sciences Investment Outlook, eight industries and subsectors were analyzed by macroeconomic and geopolitical upheaval and how deal activity and

The STEM workforce, expected to grow 11% by 2031 according to the US Department of Labor, is an area of continual advancement, vital for future

While the life science real estate market may be slowing to some, life science experts believe it is still strong and stabilizing itself after vacancies

Dr. Nora Disis, director of the Cancer Vaccine Institute at UW Medicine and a University of Washington and Fred Hutch Cancer Center faculty member, is close to a breakthrough breast cancer

University of Washington spinout Abacus Bioscience has raised $4.4 million as part of an ongoing seed round. The company led by Seagen veterans has potentially

There are some cities in the United States better than others for STEM professionals, according to a new study by WalletHub. The study analyzed the

COVID-19 put a strain on multiple industries over the last few years, but several Spokane leaders in biosciences and healthcare are focused on supporting their

Four years after its launch, Seattle-based company Sana Biotechnology announced FDA approval to start clinical trials for its allogeneic CAR-T cell therapy treatment. The SC291

Seattle-based startup Myosana Therapeutics raised $5 million to develop an early-stage candidate treatment for Duchenne muscular dystrophy (DMD).  DMD is caused by mutations in the largest

Seattle-based biotech Parse Biosciences has moved to a 34,000-square-foot facility at the new Dexter Yard development in South Lake Union. The new building is an

Seattle is the place to be in 2023, filled with lots of optimism, new beginnings and exciting breakthroughs for the year ahead. Investments are running

Washington-based AGC Biologics has been chosen to help manufacture Provention Bio’s Type 1 juvenile diabetes treatment. The treatment had been in development for over 36